The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities
Open accessAbstract
Importance: The association of bariatric surgery and specialized medical obesity treatment with beneficial and detrimental outcomes remains uncertain. Objective: To compare changes in obesity-related comorbidities in patients with severe obesity (body mass index ≥40 or ≥35 and at least 1 comorbidity) undergoing bariatric surgery or specialized medical treatment. Design, Setting, and Participants: Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included). Exposures: Bariatric surgery (n = 932, 92% gastric bypass) or specialized medical treatment (n = 956) including individual or group-based lifestyle intervention programs. Main Outcomes and Measures: Primary outcomes included remission and new onset of hypertension based on drugs dispensed according to the Norwegian Prescription Database. Prespecified secondary outcomes included changes in comorbidities. Adverse events included complications retrieved from the Norwegian Patient Registry and a local laboratory database. Results: Among 1888 patients included in the study, the mean (SD) age was 43.5 (12.3) years (1249 women [66%]; mean [SD] baseline BMI, 44.2 [6.1]; 100% completed follow-up at a median of 6.5 years [range, 0.2-10.1]). Surgically treated patients had a greater likelihood of remission and lesser likelihood for new onset of hypertension (remission: absolute risk [AR], 31.9% vs 12.4%); risk difference [RD], 19.5% [95% CI, 15.8%-23.2%], relative risk [RR], 2.1 [95% CI, 2.0-2.2]; new onset: AR, 3.5% vs 12.2%, RD, 8.7% [95% CI, 6.7%-10.7%], RR, 0.4 [95% CI, 0.3-0.5]; greater likelihood of diabetes remission: AR, 57.5% vs 14.8%; RD, 42.7% [95% CI, 35.8%-49.7%], RR, 3.9 [95% CI, 2.8-5.4]; greater risk of new-onset depression: AR, 8.9% vs 6.5%; RD, 2.4% [95% CI, 1.3%-3.5%], RR, 1.5 [95% CI, 1.4-1.7]; and treatment with opioids: AR, 19.4% vs 15.8%, RD, 3.6% [95% CI, 2.3%-4.9%], RR, 1.3 [95% CI, 1.2-1.4]). Surgical patients had a greater risk for undergoing at least 1 additional gastrointestinal surgical procedure (AR, 31.3% vs 15.5%; RD, 15.8% [95% CI, 13.1%-18.5%]; RR, 2.0 [95% CI, 1.7-2.4]). The proportion of patients with low ferritin levels was significantly greater in the surgical group (26% vs 12%, P < .001). Conclusions and Relevance: Among patients with severe obesity followed up for a median of 6.5 years, bariatric surgery compared with medical treatment was associated with a clinically important increased risk for complications, as well as lower risks of obesity-related comorbidities. The risk for complications should be considered in the decision-making process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bariatric surgery and endoscopic procedures are important therapeutic options in persons with T2D and ABCD.777–781”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [778]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In clinical trials comparing bariatric surgery vs medical treatment in persons with T2D, bariatric surgery results in greater short-term and long-term lowering of A1C, including remission of T2D in some persons.777–783”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [778]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755 · cited 1×
“53 Duration of diabetes, median (range), y 4 (1-38) 5 (0-37) .”
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867
Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., Bucher, H. C., & Nordmann, A. J. (2013) · BMJ · doi:10.1136/bmj.f5934 · Cited by 1,351
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Adams, T. D., Davidson, L. E., Litwin, S. E., Kim, J., Kolotkin, R. L., Nanjee, M. N., Gutierrez, J. M., Frogley, S. J., Ibele, A. R., Brinton, E. A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700459 · Cited by 956
Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
The Look AHEAD Research Group (2014) · Obesity · doi:10.1002/oby.20662 · Cited by 842
Long-term Follow-up After Bariatric Surgery: A Systematic Review
Puzziferri, N., Roshek, T. B., Mayo, H. G., Gallagher, R., Belle, S. H., & Livingston, E. H. (2014) · JAMA · doi:10.1001/jama.2014.10706 · Cited by 819
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects
Carlsson, L. M. S., Peltonen, M., Ahlin, S., Anveden, Å., Bouchard, C., Carlsson, B., Jacobson, P., Lönroth, H., Maglio, C., Näslund, I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112082 · Cited by 794
Ikramuddin, S., Korner, J., Lee, W.-J., Connett, J. E., Inabnet, W. B., Billington, C. J., Thomas, A. J., Leslie, D. B., Chong, K., Jeffery, R. W., et al. (2013) · JAMA · doi:10.1001/jama.2013.5835 · Cited by 735
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
(2016) · New England Journal of Medicine · doi:10.1056/nejmc1600827 · Cited by 700
Health benefits of gastric bypass surgery after 6 years
Adams, T. D., Davidson, L. E., Litwin, S. E., Kolotkin, R. L., LaMonte, M. J., Pendleton, R. C., Strong, M. B., Vinik, R., Wanner, N. A., Hopkins, P. N., et al. (2012) · JAMA · doi:10.1001/2012.jama.11164 · Cited by 674
Kalarchian, M. A., Marcus, M. D., Levine, M. D., Courcoulas, A. P., Pilkonis, P. A., Ringham, R. M., Soulakova, J. N., Weissfeld, L. A., & Rofey, D. L. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.328 · Cited by 616
The Nordic Countries as a Cohort for Pharmacoepidemiological Research
Furu, K., Wettermark, B., Andersen, M. T., Martikainen, J. E., Almarsdóttir, A. B., & Sørensen, H. T. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00494.x · Cited by 588
Mental Health Conditions Among Patients Seeking and Undergoing Bariatric Surgery: A Meta-analysis
Dawes, A. J., Maggard-Gibbons, M., Maher, A. R., Booth, M. J., Miake-Lye, I., Beroes, J. M., & Shekelle, P. G. (2016) · JAMA · doi:10.1001/jama.2015.18118 · Cited by 579
Executive summary: Guidelines (2013) for the management of overweight and obesity in adults
Members, E. P., Jensen, M. D., Ryan, D. H., Donato, K. A., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Hu, F. B., Hubbard, V. S., Jakicic, J. M., et al. (2014) · Obesity · doi:10.1002/oby.20821 · Cited by 350
Statins for the primary prevention of cardiovascular disease
Ebrahim, S. B. J., Taylor, F. C., & Brindle, P. (2014) · BMJ · doi:10.1136/bmj.g280 · Cited by 335
Stenberg, E., Szabó, É., Ågren, G., Ottosson, J., Marsk, R., Lönroth, H., Boman, L., Magnuson, A., Thorell, A., & Näslund, I. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01126-5 · Cited by 293
Mechanisms, Pathophysiology, and Management of Obesity
Sheu, N.-W., Lin, Y.-C., & Chen, C.-J. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1701944 · Cited by 266
Risstad, H., Søvik, T. T., Engström, M., Aasheim, E. T., Fagerland, M. W., Olsén, M. F., Kristinsson, J. A., le Roux, C. W., Bøhmer, T., Birkeland, K. I., et al. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.3579 · Cited by 230
Mitchell, J. E., King, W. C., Chen, J., Devlin, M. J., Flum, D. R., Garcia, L., Inabet, W., Pender, J. R., Kalarchian, M. A., Khandelwal, S., et al. (2014) · Obesity · doi:10.1002/oby.20738 · Cited by 216
Hofsø, D., Nordstrand, N., Johnson, L. K., Karlsen, T., Hager, H. B., Jenssen, T. G., Bollerslev, J., Godang, K., Sandbu, R., Røislien, J., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0514 · Cited by 213
Self-citationSalam, M. M., Yousuf, R., Salam, M. M., & Haque, M. (2023) · Advances in Human Biology · doi:10.4103/aihb.aihb_106_22 · Cited by 188
Douglas, I., Bhaskaran, K., Batterham, R. L., & Smeeth, L. L. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001925 · Cited by 180
Sox, H. C., & Lewis, R. J. (2016) · JAMA · doi:10.1001/jama.2016.11409 · Cited by 139
Kalarchian, M. A. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.2.328 · Cited by 137
Prevalence of Self-reported Symptoms After Gastric Bypass Surgery for Obesity
Gribsholt, S. B., Pedersen, A. M., Svensson, E., Thomsen, R. W., & Richelsen, B. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2015.5110 · Cited by 132
Chronic Abdominal Pain and Symptoms 5 Years After Gastric Bypass for Morbid Obesity
Høgestøl, I. K. D., Chahal-Kummen, M., Eribe, I., Brunborg, C., Stubhaug, A., Hewitt, S., Kristinsson, J. A., & Mala, T. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2499-z · Cited by 110
Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study
Booth, H., Khan, O., Prevost, T., Reddy, M., Dregan, A., Charlton, J., Ashworth, M., Rudisill, C., Littlejohns, P., & Gulliford, M. C. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70214-1 · Cited by 101
King, W. C., Chen, J.-Y., Belle, S. H., Courcoulas, A. P., Dakin, G. F., Flum, D. R., Hinojosa, M. W., Kalarchian, M. A., Mitchell, J. E., Pories, W. J., et al. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.04.003 · Cited by 100
Booth, H., Khan, O. A., Prevost, A. T., Reddy, M., Charlton, J., & Gulliford, M. C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.050 · Cited by 80
Unexplained abdominal pain in morbidly obese patients after bariatric surgery
Pierik, A. S., Coblijn, U. K., de Raaff, C. A. L., van Veen, R. N., van Tets, W. F., & van Wagensveld, B. A. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.05.027 · Cited by 55
Morbidly Obese Patients—Who Undergoes Bariatric Surgery?
Jakobsen, G. S., Hofsø, D., Røislien, J., Sandbu, R., & Hjelmesaeth, J. S. (2010) · Obesity Surgery · doi:10.1007/s11695-009-0053-y · Cited by 47
Self-citationFischer, L., Nickel, F., Sander, J., Ernst, A., Bruckner, T. M., Herbig, B., Büchler, M. W., Müller-Stich, B. P., & Sandbu, R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.02.040 · Cited by 43
Self-citationØvrebø, B., Strømmen, M., Kulseng, B. E., & Martins, C. (2017) · Clinical Obesity · doi:10.1111/cob.12190 · Cited by 32
Hospital admission after gastric bypass: a nationwide cohort study with up to 6 years follow-up
Bruze, G., Ottosson, J., Neovius, M., Näslund, I., & Marsk, R. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.01.004 · Cited by 23
(2000) · Time to knit · doi:10.1016/j.ysur.2016.03.142 · Cited by 21
Valderhaug, T. G., Aasheim, E. T., Sandbu, R., Jakobsen, G. S., Småstuen, M. C., Hertel, J. K., & Hjelmesaeth, J. S. (2016) · BMC Obesity · doi:10.1186/s40608-016-0133-1 · Cited by 20
Self-citationGjevestad, E. S., Hjelmesaeth, J. S., Sandbu, R., & Nordstrand, N. (2014) · Obesity · doi:10.1002/oby.20880 · Cited by 13
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442
Mechanick, J. I., Apovian, C. M., Brethauer, S. A., Garvey, W. T., Joffe, A. M., Kim, J. J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 425
Metadata
- Authors
- Jakobsen, G. S., Småstuen, M. C., Sandbu, R., Nordstrand, N., Hofsø, D., Lindberg, M., Hertel, J. K., & Hjelmesæth, J.
- Affiliations
- Sykehuset i Vestfold (NO)
- Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-01-16
- Volume
- 319
- Issue
- 3
- Pages
- 291
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC5833560
- OpenAlex
- W2784324162
- Cited by
- 358
- References
- 43
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 43 · 2023: 50 · 2022: 44 · 2021: 53 · 2020: 50 · 2019: 44 · 2018: 32
- FWCI
- 46.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Keywords
- bariatric surgery, morbid obesity, lifestyle intervention, gastric bypass, diabetes remission, hypertension remission, obesity-related comorbidities, postoperative complications, long-term outcomes, weight loss, prescription drug dispensing, patient registry data, United States comparison, cost-effectiveness, quality of life, patient satisfaction
- MeSH terms
- Adult, Depression, Diabetes Mellitus, Type 2, Female, Ferritins, Humans, Hypertension, Male, Middle Aged, Obesity, Morbid, Remission Induction, Cohort Studies, Comorbidity, Body Mass Index, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review